CD8⁺ T Cell Exhaustion During Persistent Viral Infection is Regulated Independently of the Virus-Specific T Cell Receptor

REFERENCES

• Agnellini, P., Wolint, P., Rehr, M., Cahenzli, J., Karrer, U., Oxenius, A. (2007). Impaired NFAT nuclear translocation results in split exhaustion of virus-specific CD8+ T cell functions during chronic viral infection. Proc. Natl. Acad. Sci. U S A 104: 4565–4570.
   PubMed Web of Science ®Google Scholar
• Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., Ahmed, R. (2006). Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682–687.
   PubMed Web of Science ®Google Scholar
• Blackburn, S. D., Shin, H., Haining, W. N., Zou, T., Workman, C. J., Polley, A., Betts, M. R., Freeman, G. J., Vignali, D. A., Wherry, E. J. (2009). Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat. Immunol. 10: 29–37.
   PubMed Web of Science ®Google Scholar
• Blattman, J. N., Grayson, J. M., Wherry, E. J., Kaech, S. M., Smith, K. A., Ahmed, R. (2003). Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nat. Med. 9: 540–547.
   PubMed Web of Science ®Google Scholar
• Bollard, C. M., Rossig, C., Calonge, M. J., Huls, M. H., Wagner, H. J., Massague, J., Brenner, M. K., Heslop, H. E., Rooney, C. M. (2002). Adapting a transforming growth factor beta-related tumor protection strategy to enhance antitumor immunity. Blood 99: 3179–3187.
   PubMed Web of Science ®Google Scholar
• Boni, C., Fisicaro, P., Valdatta, C., Amadei, B., Di Vincenzo, P., Giuberti, T., Laccabue, D., Zerbini, A., Cavalli, A., Missale, G., Bertoletti, A., Ferrari, C. ( 2007). Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J. Virol. 81: 4215–4225.
   PubMed Web of Science ®Google Scholar
• Brooks, D. G., Lee, A. M., Elsaesser, H., McGavern, D. B., Oldstone, M. B. (2008). IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection. J. Exp. Med. 205: 533–541.
   PubMed Web of Science ®Google Scholar
• Cecchinato, V., Tryniszewska, E., Ma, Z. M., Vaccari, M., Boasso, A., Tsai, W. P., Petrovas, C., Fuchs, D., Heraud, J. M., Venzon, D., Shearer, G. M., Koup, R. A., Lowy, I., Miller, C. J., Franchini, G. (2008). Immune activation driven by CTLA-4 blockade augments viral replication at mucosal sites in simian immunodeficiency virus infection. J. Immunol. 180: 5439–5447.
   PubMed Web of Science ®Google Scholar
• Curran, M. A., Allison, J. P. (2009). Tumor vaccines expressing flt3 ligand synergize with ctla-4 blockade to reject preimplanted tumors. Cancer Res 69: 7747–7755.
   PubMed Web of Science ®Google Scholar
• Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W., Miller, J. D., Leslie, A. J., DePierres, C., Mncube, Z., Duraiswamy, J., Zhu, B., Eichbaum, Q., Altfeld, M., Wherry, E. J., Coovadia, H. M., Goulder, P. J., Klenerman, P., Ahmed, R., Freeman, G. J., Walker, B. D. (2006). PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443: 350–354.
   PubMed Web of Science ®Google Scholar
• Eggena, M. PP., Barugahare, B., Jones, N., Okello, M., Mutalya, S., Kityo, C., Mugyenyi, P., Cao, H. (2005). Depletion of regulatory T cells in HIV infection is associated with immune activation. J. Immunol. 174: 4407–4414.
   PubMed Web of Science ®Google Scholar
• Ejrnaes, M., Filippi, C. M., Martinic, M. M., Ling, E. M., Togher, L. M., Crotty, S., von Herrath, M. G. (2006). Resolution of a chronic viral infection after interleukin-10 receptor blockade. J. Exp. Med. 203: 2461–2472.
   PubMed Web of Science ®Google Scholar
• Ercolini, A. M., Ladle, B. H., Manning, E. A., Pfannenstiel, L. W., Armstrong, T. D., Machiels, J. P., Bieler, J. G., Emens, L. A., Reilly, R. T., Jaffee, E. M. (2005). Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response. J. Exp. Med. 201: 1591–1602.
   PubMed Web of Science ®Google Scholar
• Fujio, K., Okamura, T., Yamamoto, K. (2010). The Family of IL-10-secreting CD4+ T cells. Adv. Immunol. 105: 99–130.
   PubMed Web of Science ®Google Scholar
• Goldberg, M. V., Maris, C. H., Hipkiss, E. L., Flies, A. S., Zhen, L., Tuder, R. M., Grosso, J. F., Harris, T. J., Getnet, D., Whartenby, K. A., Brockstedt, D. G., Dubensky, T. W., Jr., Chen, L., Pardoll, D. M., Drake, C. G. 2007. Role of PD-1 and its ligand, B7H1, in early fate decisions of CD8 T cells. Blood 110: 186–192.
   PubMed Web of Science ®Google Scholar
• Grosso, J. F., Kelleher, C. C., Harris, T. J., Maris, C. H., Hipkiss, E. L., De Marzo, A., Anders, R., Netto, G., Getnet, D., Bruno, T. C., Goldberg, M. V., Pardoll, D. M., Drake, C. G. (2007). LAG-3 regulates CD8+ T cell accumulation and effector function in murine self-and tumor-tolerance systems. J. Clin. Invest. 117: 3383–3392.
   PubMed Web of Science ®Google Scholar
• Ha, S. J., Mueller, S. N., Wherry, E. J., Barber, D. L., Aubert, R. D., Sharpe, A. H., Freeman, G. J., Ahmed, R. (2008). Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection. J. Exp. Med. 205: 543–555.
   PubMed Web of Science ®Google Scholar
• Hernandez, J., Aung, S., Redmond, W. L., Sherman, L. A. (2001). Phenotypic and functional analysis of CD8(+) T cells undergoing peripheral deletion in response to cross-presentation of self-antigen. J. Exp. Med. 194: 707–717.
   PubMed Web of Science ®Google Scholar
• Kim, P. S., Ahmed, R. (2010). Features of responding T cells in cancer and chronic infection. Curr. Opin. Immunol. 22: 223–230.
   PubMed Web of Science ®Google Scholar
• Lucas, C. L., Workman, C. J., Beyaz, S., LoCascio, S., Zhao, G., Vignali, D. A., Sykes, M. (2011). LAG-3, TGF-beta, and cell-intrinsic PD-1 inhibitory pathways contribute to CD8 but not CD4 T-cell tolerance induced by allogeneic BMT with anti-CD40L. Blood 117: 5532–5540.
   PubMedGoogle Scholar
• Martin-Orozco, N., Wang, Y. H., Yagita, H., Dong, C. (2006). Cutting Edge: Programmed death (PD) ligand-1/PD-1 interaction is required for CD8+ T cell tolerance to tissue antigens. J. Immunol. 177: 8291–8295.
   PubMed Web of Science ®Google Scholar
• Moskophidis, D., Lechner, F., Pircher, H., Zinkernagel, R. M. (1993). Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362: 758–761.
   PubMed Web of Science ®Google Scholar
• Mueller, K., Schweier, O., Pircher, H. (2008). Efficacy of IL-2-versus IL-15-stimulated CD8 T cells in adoptive immunotherapy. Eur. J. Immunol. 38: 2874–2885.
   PubMedGoogle Scholar
• Ohlen, C., Kalos, M., Cheng, L. E., Shur, A. C., Hong, D. J., Carson, B. D., Kokot, N. C., Lerner, C. G., Sather, B. D., Huseby, E. S., Greenberg, P. D. (2002). CD8(+) T cell tolerance to a tumor-associated antigen is maintained at the level of expansion rather than effector function. J. Exp. Med. 195: 1407–1418.
   Google Scholar
• Pablo Penaloza-MacMaster, K. A., Alice Kamphorst, A., Smita Iyer, S., Erin West, E., Bogna Konieczny, B.,Gordon Freeman, G., Alexander Rudenski, A., and Rafi Ahmed, R. (2011). FoxP3+ CD4+ cells promote CD8 T cell exhaustion during chronic infection The J. Immunol. 186: 105.5.
   Google Scholar
• Probst, H. C., McCoy, K., Okazaki, T., Honjo, T., van den Broek, M. (2005). Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4. Nat. Immunol. 6: 280–286.
   PubMed Web of Science ®Google Scholar
• Quezada, S. A., Peggs, K. S., Curran, M. A., Allison, J. P. (2006). CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells. J. Clin. Invest. 116: 1935–1945.
   PubMed Web of Science ®Google Scholar
• Radziewicz, H., Ibegbu, C. C., Fernandez, M. L., Workowski, K. A., Obideen, K., Wehbi, M., Hanson, H. L., Steinberg, J. P., Masopust, D., Wherry, E. J., Altman, J. D., Rouse, B. T., Freeman, G. J., Ahmed, R., Grakoui, A. (2007). Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J. Virol. 81: 2545–2553.
   PubMed Web of Science ®Google Scholar
• Schietinger, A., Delrow, J. J., Basom, R. S., Blattman, J. N., Greenberg, P. D. (2012). Rescued tolerant CD8 T cells are preprogrammed to reestablish the tolerant state. Science 335: 723–727.
   PubMed Web of Science ®Google Scholar
• Shin, H., Wherry, E. J. (2007). CD8 T cell dysfunction during chronic viral infection. Curr. Opin. Immunol. 19: 408–415.
   PubMed Web of Science ®Google Scholar
• Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., (1992). Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359: 693–699.
   PubMed Web of Science ®Google Scholar
• Teague, R. M., Greenberg, P. D., Fowler, C., Huang, M. Z., Tan, X., Morimoto, J., Dossett, M. L., Huseby, E. S., Ohlen, C. (2008). Peripheral CD8+ T cell tolerance to self-proteins is regulated proximally at the T cell receptor. Immunity 28: 662–674 .
   PubMed Web of Science ®Google Scholar
• Tinoco, R., Alcalde, V., Yang, Y., Sauer, K., Zuniga, E. I. (2009). Cell-intrinsic transforming growth factor-beta signaling mediates virus-specific CD8+ T cell deletion and viral persistence in vivo. Immunity 31: 145–157.
   PubMedGoogle Scholar
• Trautmann, L., Janbazian, L., Chomont, N., Said, E. A., Gimmig, S., Bessette, B., Boulassel, M. R., Delwart, E., Sepulveda, H., Balderas, R. S., Routy, J. P., Haddad, E. K., Sekaly, R. P. (2006). Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat. Med. 12: 1198–1202.
   PubMed Web of Science ®Google Scholar
• Vicari, A. P., Chiodoni, C., Vaure, C., Ait-Yahia, S., Dercamp, C., Matsos, F., Reynard, O., Taverne, C., Merle, P., Colombo, M. P., O’Garra, A., Trinchieri, G., Caux, C. (2002). Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody. J. Exp. Med. 196: 541–549.
   PubMed Web of Science ®Google Scholar
• Wherry EJ, Ha SJ, Kaech SM, Haining WN, Sarkar S, Kalia V, Subramaniam S, Blattman JN, Barber DL, Ahmed R. 2007. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27: 670–84.
   PubMed Web of Science ®Google Scholar
• Wherry, E. J., Blattman, J. N., Ahmed, R. (2005). Low CD8 T-cell proliferative potential and high viral load limit the effectiveness of therapeutic vaccination. J. Virol. 79: 8960–8968.
   Google Scholar
• Wherry, E. J., Blattman, J. N., Murali-Krishna, K., van der Most, R., Ahmed, R. (2003). Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77: 4911–4927.
   PubMed Web of Science ®Google Scholar
• Wilson, E. B., Brooks, D. G. (2010). Translating insights from persistent LCMV infection into anti-HIV immunity. Immunol. Res. 48: 3–13.
   Google Scholar
• Xie, Z., Chen, Y., Zhao, S., Yang, Z., Yao, X., Guo, S., Yang, C., Fei, L., Zeng, X., Ni, B., Wu, Y. (2009). Intrahepatic PD1/PD-L1 up-regulation closely correlates with inflammation and virus replication in patients with chronic HBV infection. Immunol. Invest. 38: 624–638.
   PubMed Web of Science ®Google Scholar
• Yao, Z. Q., Ni, L., Zhang, Y., Ma, C. J., Zhang, C. L., Dong, Z. P., Frazier, A. D., Wu, X. Y., Thayer, P., Borthwick, T., Chen, X. Y., Moorman, J. P. (2011). Differential regulation of T and B lymphocytes by PD-1 and SOCS-1 signaling in hepatitis C virus-associated non-Hodgkin’s lymphoma. Immunol. Invest. 40: 243–264.
   PubMed Web of Science ®Google Scholar
• Youngblood B, Oestreich KJ, Ha SJ, Duraiswamy J, Akondy RS, West EE, Wei Z, Lu P, Austin JW, Riley JL, Boss JM, Ahmed R. 2011. Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8(+) T cells. Immunity 35: 400–12.
   PubMed Web of Science ®Google Scholar
• Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J., Suresh, M., Altman, J. D., Ahmed, R. (1998). Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188: 2205–2213.
   PubMed Web of Science ®Google Scholar
• Zhang, Q., Yang, X., Pins, M., Javonovic, B., Kuzel, T., Kim, S. J., Parijs, L. V., Greenberg, N. M., Liu, V., Guo, Y., Lee, C. (2005). Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer. Cancer Res. 65: 1761–1769.
   PubMed Web of Science ®Google Scholar